menu
    • menu

    Company profile for Maxwell Biosciences

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 2016, Maxwell Biosciences is a preclinical stage drug platform company actively developing an entirely new class of patented, virucidal, small molecule drugs called Claromers™. This novel drug class mimics natural antimicrobial peptides to safely and permanently inactivate viruses. Maxwell is led by a world-class team of scientists and experienced executives who are continuously innovating and submitting new paten...
    Founded in 2016, Maxwell Biosciences is a preclinical stage drug platform company actively developing an entirely new class of patented, virucidal, small molecule drugs called Claromers™. This novel drug class mimics natural antimicrobial peptides to safely and permanently inactivate viruses. Maxwell is led by a world-class team of scientists and experienced executives who are continuously innovating and submitting new patent applications each month.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Maxwell BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3809 Juniper Trace, Ste 102 Austin, Texas 78738
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://maxwellbiosciences.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Maxwell Biosciences Names Two Biotech Leaders to Its Board of Directors
    Maxwell Biosciences Names Two Biotech Leaders to Its Board of Directors

    07 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221107005236/en

    BUSINESSWIRE
    07 Nov 2022
    Share Share
    Maxwell Announces In Vivo and In Vitro Data on CLAROMER Platform’s Ability
    Maxwell Announces In Vivo and In Vitro Data on CLAROMER Platform’s Ability

    29 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220929005223/en

    BUSINESSWIRE
    29 Sep 2022
    Share Share
    Maxwell Biosciences Announces In Vivo and In Vitro Data on CLAROMER 
    Maxwell Biosciences Announces In Vivo and In Vitro Data on CLAROMER 

    29 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220929005223/en/Maxwell-Biosciences-Announces-In-Vivo-and-In-Vitro-Data-on-CLAROMER%E2%84%A2-Platform%E2%80%99s-Ability-to-Treat-and-Prevent-SARS-CoV-2-and-Other-Respiratory-Viruses-at-OPTIONS-XI-Conference

    BUSINESSWIRE
    29 Sep 2022
    Share Share
    Maxwell Biosciences Expands Leadership Team with the Appointment
    Maxwell Biosciences Expands Leadership Team with the Appointment

    20 Sep 2022

    // FIRSTWORLDPHARMA

    https://firstwordpharma.com/story/5654528

    FIRSTWORLDPHARMA
    20 Sep 2022
    Share Share
    Maxwell Biosciences Announces the Appointment of Edward Rudnic
    Maxwell Biosciences Announces the Appointment of Edward Rudnic

    21 Apr 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220421005285/en

    BUSINESSWIRE
    21 Apr 2022
    Share Share
    Maxwell Biosciences Raises $10.8 Million in Oversubscribed Seed Round
    Maxwell Biosciences Raises $10.8 Million in Oversubscribed Seed Round

    10 Mar 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220310005875/en

    BUSINESSWIRE
    10 Mar 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search